M&A or MIA?
After witnessing watershed deals in the past few years, the M&A scenario in India seems to be MIA: missing in action. However,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Venus Remedies bags patent for Vancoplus from Canada
Venus Remedies has secured its first patent from Canada for its novel antibiotic adjuvant entity ‘Vancoplus’.
CDSCO to increase headcount of NDAC, MDAC committees
The last date for submitting the applications are on September 28, 2012
Orchid Pharma signs agreement with Hospira for $200 m
To transfer its penicillin and penem API business and its API facilities in Aurangabad
US FDA to continue review of Crofelemer new drug application
FDA action on Crofelemer NDA anticipated by end of 1Q-CY2013
Wockhardt gets US FDA nod for Parkinsonism drug Requip XL
The drug will be manufactured at its facility in Aurangabad
AYUSH proposes to set up Central Drug Controller Office
Gets approval of Rs 80 lakh from Department of Expenditure
Sun Pharma ranks 38 in Forbes 100 innovative companies list
One of five Indian companies in the listing
India to draw blueprint to curb spurious and not-of-standard medicines soon
International consultation on developing blueprint to combat spurious drugs with use of technology
AsiaPac records highest fall in volume of pharma M&A in August: MedTRACK
M&A activity in the pharmaceutical market recorded a downturn of 38 per cent in August